SAVA - CASSAVA SCIENCES INC

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 3.78

Open

$ 3.97

Bid

$ 3.75 x 8

Ask

$ 4.00 x 5

Day's Range

$ 3.75 - $ 4.01

52 Week Range

$ 1.15 - $ 33.98

Volume

1,728,887

Average Volume

Market Cap

182.6M

Beta (5Y Monthly)

$ 1.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-01-2023	03-31-2023	10-Q
11	02-28-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-04-2021	06-30-2021	10-Q
18	04-29-2021	03-31-2021	10-Q
19	03-23-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K
24	10-29-2019	09-30-2019	10-Q
25	08-12-2019	06-30-2019	10-Q
26	05-02-2019	03-31-2019	10-Q
27	03-29-2019	12-31-2018	10-K
28	10-30-2018	09-30-2018	10-Q
29	07-26-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	02-06-2018	12-31-2017	10-K
32	11-01-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	04-26-2017	03-31-2017	10-Q
35	03-07-2017	12-31-2016	10-K
36	10-26-2016	09-30-2016	10-Q
37	07-19-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	03-03-2016	12-31-2015	10-K
40	11-09-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cassava Sciences Says U.S. Court Dismisses...
10/24/2025 12:14:23

- SEC Filing

LUCID CAPITAL MARKETS Initiates Coverage O...
10/06/2025 12:50:40

LUCID CAPITAL MARKETS analyst Elemer Piros initiates coverage on Cassava Sciences (NASDAQ:SAVA) with a Buy rating and announ...

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 17:06:52

cassava-sciences-sava-stock-is-surging-tuesday-whats-going-on

Cassava Sciences (SAVA) Stock Is Surging T...
09/23/2025 14:19:22

Cassava Sciences shares are trading higher Tuesday morning. A Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shar...

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 12:09:16

why-super-league-enterprise-shares-are-trading-higher-by-200-here-are-20-stocks-moving-premarket

Why Super League Enterprise Shares Are Tra...
09/23/2025 09:41:19

12 Health Care Stocks Moving In Monday's A...
09/22/2025 21:06:10

Cassava Sciences Form4 Filing Shows CEO Ri...
09/22/2025 20:22:59

- SEC Filing

Cassava Sciences Q2 EPS $(0.92) Down From ...
08/14/2025 11:35:38

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.92) per share. This is a 807.69 percent decrease over earnings ...

Cassava Sciences Reports Preclinical Resul...
08/04/2025 11:33:04

The Tsc1-CKO mice were treated with several doses of simufilam. Seizure activity was monitored for approximately three weeks af...

Cassava Sciences Presented A Poster At The...
06/30/2025 11:02:08

The poster detailed two important observations that support Cassava's plan to initiate human clinical studies in H1 2026 to...

'FDA Clears First Blood Test Used In Diagn...
05/16/2025 17:32:57

https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%...

Cassava Sciences Q1 EPS $(0.48) Down From ...
05/08/2025 12:14:14

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.48) per share. This is a 11.63 percent decrease over losses of ...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
03/25/2025 17:05:55

HC Wainwright & Co. Reiterates Neutral on ...
03/25/2025 15:40:19

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Neutral and maintains $2 ...

cassava-sciences-discontinues-developing-simufilam-for-alzheimers-after-another-phase-3-trial-flop

Cassava Sciences Discontinues Developing S...
03/25/2025 14:42:19

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus...

Cassava Sciences Reports Topline Phase 3 R...
03/25/2025 12:13:04

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in pat...

HC Wainwright & Co. Reiterates Neutral on ...
03/04/2025 17:23:59

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) from Neutral to Neutral.

tesla-rebounds-while-tariffs-weigh-on-manufacturing-whats-driving-markets-monday

Tesla Rebounds While Tariffs Weigh On Manu...
03/03/2025 17:18:23

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digeste...

Cassava Sciences Q4 2024 GAAP EPS $(0.57) ...
03/03/2025 12:32:52

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0....

These Small Caps Are Betting Big On Americ...
10/19/2020 13:20:40